C4 Therapeutics Initiates Phase 1B Trial For Cemsidomide
25 Mar 2026 //
GLOBENEWSWIRE
C4 Therapeutics Doses First Patient in Phase 2 MOMENTUM Trial
23 Feb 2026 //
GLOBENEWSWIRE
C4 Therapeutics Advances Cemsidomide As Top IKZF1/3 Degrader
14 Jan 2026 //
GLOBENEWSWIRE

Market Place
Sourcing Support